Compérat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400(10364):1712–21.

Article  PubMed  Google Scholar 

Nuhn P, May M, Sun M, Fritsche H-M, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, et al. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol. 2012;61(1):58–64.

Article  PubMed  Google Scholar 

Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res Off J Am Assoc Cancer Res. 2006;12(22):6663–76.

Article  Google Scholar 

Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–70.

Article  PubMed  Google Scholar 

Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13(2):111–6.

Article  PubMed  Google Scholar 

Mariani L, Miceli R, Kattan MW, Brennan MF, Colecchia M, Fiore M, Casali PG, Gronchi A. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103(2):402–8.

Article  PubMed  Google Scholar 

Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. The cancer of the bladder risk assessment (COBRA) score: estimating mortality after radical cystectomy. Cancer. 2017;123(23):4574–82.

Article  CAS  PubMed  Google Scholar 

Lai S, Liu J, Lai C-H, Seery S, Hu H, Wang M, Hu H, Xu T. Prognostic variations between ‘primary’ and ‘progressive’ muscle-invasive bladder cancer following radical cystectomy: a novel propensity score-based multicenter cohort study. Int J Surg. 2024;110(1):270–9.

Article  PubMed  Google Scholar 

Moschini M, Sharma V, Dell’oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, et al. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy. BJU Int. 2016;117(4):604–10.

Article  PubMed  Google Scholar 

Rouprêt M, Seisen T, Birtle AJ, Capoun O, Compérat EM, Dominguez-Escrig JL, Gürses Andersson I, Liedberg F, Mariappan P, Hugh Mostafid A, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84(1):49–64.

Article  PubMed  Google Scholar 

Pietzak EJ, Zabor EC, Bagrodia A, Armenia J, Hu W, Zehir A, Funt S, Audenet F, Barron D, Maamouri N, et al. Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy. Eur Urol. 2019;75(2):231–9.

Article  PubMed  Google Scholar 

Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, et al. Assessment of predictive genomic biomarkers for response to cisplatin-based neoadjuvant chemotherapy in bladder cancer. Eur Urol. 2023;83(4):313–7.

Article  CAS  PubMed  Google Scholar 

Taber A, Christensen E, Lamy P, Nordentoft I, Prip F, Lindskrog SV, Birkenkamp-Demtröder K, Okholm TLH, Knudsen M, Pedersen JS, et al. Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nat Commun. 2020;11(1):4858.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hurst CD, Knowles MA. Mutational landscape of non-muscle-invasive bladder cancer. Urol Oncol. 2022;40(7):295–303.

Article  CAS  PubMed  Google Scholar 

Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao X, Tang Y, Ren H, Lei Y. Identification of prognosis-related genes in bladder cancer microenvironment across TCGA database. Biomed Res Int. 2020;2020:9143695.

Article  PubMed  PubMed Central  Google Scholar 

Urabe F, Patil K, Ramm GA, Ochiya T, Soekmadji C. Extracellular vesicles in the development of organ-specific metastasis. J Extracell Vesicles. 2021;10(9):e12125.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gangoda L, Liem M, Ang C-S, Keerthikumar S, Adda CG, Parker BS, Mathivanan S. Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics. 2017;17:23–4.

Article  Google Scholar 

Frew JW, Navrazhina K, Marohn M, Lu P-JC, Krueger JG. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa. Exp Dermatol. 2019;28(8):886–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petrova V, Annicchiarico-Petruzzelli M, Melino G, Amelio I. The hypoxic tumour microenvironment. Oncogenesis. 2018;7(1):10.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Wu J, Huang W, Weng S, Wang B, Chen Y, Wang H. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J Transl Med. 2020;18(1):201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang F, Feng D, Wang X, Gu Y, Shen Z, Yang Y, Wang J, Zhong Q, Li D, Hu H, et al. An unfolded protein response related signature could robustly predict survival outcomes and closely correlate with response to immunotherapy and chemotherapy in bladder cancer. Front Mol Biosci. 2021;8:780329.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Xu MM, Wang K, Adler AJ, Vella AT, Zhou B. Macrophage polarization and meta-inflammation. Transl Res. 2018;191:29–44.

Article  CAS  PubMed  Google Scholar 

You J-A, Gong Y, Wu Y, Jin L, Chi Q, Sun D. WGCNA, LASSO and SVM algorithm revealed RAC1 correlated M0 macrophage and the risk score to predict the survival of hepatocellular carcinoma patients. Front Genet. 2021;12:730920.

Article  CAS  PubMed  Google Scholar 

Dong B, Wu C, Huang L, Qi Y. Macrophage-related SPP1 as a potential biomarker for early lymph node metastasis in lung adenocarcinoma. Front Cell Dev Biol. 2021;9:739358.

Article  PubMed  PubMed Central  Google Scholar